Home NDC 50090-6324-2 AMOXICILLIN AND CLAVULANATE POTASSIUM
Product NDC 50090-6324
Requested package NDC 50090-6324-2
11-digit product format 500906324
Labeler code 50090
Product ID 50090-6324_a2a30785-599c-4436-a3cc-b4db011b7a87
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name amoxicillin and clavulanate potassium
Dosage form TABLET, COATED
Route ORAL
Labeler A-S Medication Solutions
Application NDA050720
Marketing category NDA AUTHORIZED GENERIC
Marketing start 2022-11-21
Substance AMOXICILLIN; CLAVULANATE POTASSIUM
Active strength 875; 125 mg/1; mg/1
Pharmacologic classes Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 43 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N050720-001 AUGMENTIN '875' AMOXICILLIN; CLAVULANATE POTASSIUM 875MG;EQ 125MG BASE TABLET / ORAL AB RLD 1996-02-13
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 1 matching rows.
Application-product, TE code table Application-product TE code N050720-001 AB
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 43 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-09-14 22:38:34 2026-08 N050720-001 AUGMENTIN '875' 875MG;EQ 125MG BASE TABLET / ORAL AB RLD 1996-02-13 84e616aacf4f…2026-08-18 06:07:40 2026-07 N050720-001 AUGMENTIN '875' 875MG;EQ 125MG BASE TABLET / ORAL AB RLD 1996-02-13 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N050720-001 AUGMENTIN '875' 875MG;EQ 125MG BASE TABLET / ORAL AB RLD 1996-02-13 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N050720-001 AUGMENTIN '875' 875MG;EQ 125MG BASE TABLET / ORAL AB RLD 1996-02-13 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N050720-001 AUGMENTIN '875' 875MG;EQ 125MG BASE TABLET / ORAL AB RLD 1996-02-13 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N050720-001 AUGMENTIN '875' 875MG;EQ 125MG BASE TABLET / ORAL AB RLD 1996-02-13 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N050720-001 AUGMENTIN '875' 875MG;EQ 125MG BASE TABLET / ORAL AB RLD 1996-02-13 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N050720-001 AUGMENTIN '875' 875MG;EQ 125MG BASE TABLET / ORAL AB RLD 1996-02-13 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N050720-001 AUGMENTIN '875' 875MG;EQ 125MG BASE TABLET / ORAL AB RLD 1996-02-13 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N050720-001 AUGMENTIN '875' 875MG;EQ 125MG BASE TABLET / ORAL AB RLD 1996-02-13 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N050720-001 AUGMENTIN '875' 875MG;EQ 125MG BASE TABLET / ORAL AB RLD 1996-02-13 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N050720-001 AUGMENTIN '875' 875MG;EQ 125MG BASE TABLET / ORAL AB RLD 1996-02-13 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N050720-001 AUGMENTIN '875' 875MG;EQ 125MG BASE TABLET / ORAL AB RLD 1996-02-13 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N050720-001 AUGMENTIN '875' 875MG;EQ 125MG BASE TABLET / ORAL AB RLD 1996-02-13 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N050720-001 AUGMENTIN '875' 875MG;EQ 125MG BASE TABLET / ORAL AB RLD 1996-02-13 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N050720-001 AUGMENTIN '875' 875MG;EQ 125MG BASE TABLET / ORAL AB RLD 1996-02-13 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N050720-001 AUGMENTIN '875' 875MG;EQ 125MG BASE TABLET / ORAL AB RLD 1996-02-13 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N050720-001 AUGMENTIN '875' 875MG;EQ 125MG BASE TABLET / ORAL AB RLD 1996-02-13 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N050720-001 AUGMENTIN '875' 875MG;EQ 125MG BASE TABLET / ORAL AB RLD 1996-02-13 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 N050720-001 AUGMENTIN '875' 875MG;EQ 125MG BASE TABLET / ORAL AB RLD 1996-02-13 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 N050720-001 AUGMENTIN '875' 875MG;EQ 125MG BASE TABLET / ORAL AB RLD 1996-02-13 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 N050720-001 AUGMENTIN '875' 875MG;EQ 125MG BASE TABLET / ORAL AB RLD 1996-02-13 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N050720-001 AUGMENTIN '875' 875MG;EQ 125MG BASE TABLET / ORAL AB RLD 1996-02-13 87673890dc5c…2021-03-12 10:30 UTC 2021-03 N050720-001 AUGMENTIN '875' 875MG;EQ 125MG BASE TABLET / ORAL AB RLD 1996-02-13 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 N050720-001 AUGMENTIN '875' 875MG;EQ 125MG BASE TABLET / ORAL AB RLD 1996-02-13 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 N050720-001 AUGMENTIN '875' 875MG;EQ 125MG BASE TABLET / ORAL AB RLD 1996-02-13 c0c555d07b60…2019-12-14 00:12 UTC 2019-12 N050720-001 AUGMENTIN '875' 875MG;EQ 125MG BASE TABLET / ORAL AB RLD 1996-02-13 3f01610625f2…2019-09-15 20:21 UTC 2019-09 N050720-001 AUGMENTIN '875' 875MG;EQ 125MG BASE TABLET / ORAL AB RLD 1996-02-13 b00525d2431f…2019-07-19 19:46 UTC 2019-07 N050720-001 AUGMENTIN '875' 875MG;EQ 125MG BASE TABLET / ORAL AB RLD 1996-02-13 ea99ee380514…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 N050720-001 AUGMENTIN '875' 875MG;EQ 125MG BASE TABLET / ORAL AB RLD 1996-02-13 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 N050720-001 AUGMENTIN '875' 875MG;EQ 125MG BASE TABLET / ORAL AB RLD 1996-02-13 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 N050720-001 AUGMENTIN '875' 875MG;EQ 125MG BASE TABLET / ORAL AB RLD 1996-02-13 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 N050720-001 AUGMENTIN '875' 875MG;EQ 125MG BASE TABLET / ORAL AB RLD 1996-02-13 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 N050720-001 AUGMENTIN '875' 875MG;EQ 125MG BASE TABLET / ORAL AB RLD 1996-02-13 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 N050720-001 AUGMENTIN '875' 875MG;EQ 125MG BASE TABLET / ORAL AB RLD 1996-02-13 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 N050720-001 AUGMENTIN '875' 875MG;EQ 125MG BASE TABLET / ORAL AB RLD 1996-02-13 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 N050720-001 AUGMENTIN '875' 875MG;EQ 125MG BASE TABLET / ORAL AB RLD 1996-02-13 053a50430f4f…2023-01-26 05:58 UTC 2023-01 N050720-001 AUGMENTIN '875' 875MG;EQ 125MG BASE TABLET / ORAL AB RLD 1996-02-13 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 N050720-001 AUGMENTIN '875' 875MG;EQ 125MG BASE TABLET / ORAL AB RLD 1996-02-13 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 N050720-001 AUGMENTIN '875' 875MG;EQ 125MG BASE TABLET / ORAL AB RLD 1996-02-13 f41ea6bd6efb…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 2 · 43 observed states.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
Finished product Yes
Brand name base AMOXICILLIN AND CLAVULANATE POTASSIUM
Listing expiration 2026-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength AMOXICILLIN 875 mg/1 CLAVULANATE POTASSIUM 125 mg/1
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 2 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 804826J2HU Internal UNII lookup Q42OMW3AT8 Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 562508 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 50090-6324-0 AMOXICILLIN AND CLAVULANATE POTASSIUM 20 in 1 BOTTLE TABLET, COATED 20 4 50090-6324-1 AMOXICILLIN AND CLAVULANATE POTASSIUM 10 in 1 BOTTLE TABLET, COATED 10 4 50090-6324-2 AMOXICILLIN AND CLAVULANATE POTASSIUM 14 in 1 BOTTLE TABLET, COATED 14 4 50090-6324-3 AMOXICILLIN AND CLAVULANATE POTASSIUM 28 in 1 BOTTLE TABLET, COATED 28 4
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 50090-6324 AMOXICILLIN AND CLAVULANATE POTASSIUM TABLET, COATED [A-S MEDICATION SOLUTIONS] 4 Current NDC, 4 package rows 20240501_00cf4429-e37c-4490-b22d-3cd796124296.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 3 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Sample Exclude flag Status 50090-6324-2 50090632402 14 TABLET, COATED in 1 BOTTLE (50090-6324-2) 2023-01-12 No No Current